Obalon Therapeutics, Inc. (OBLN)

[r clarke]

In looking for news found a couple of articles pointing to a one year target of between 9 and 11

... not sure what the catalyst will be, but one positive is over 64% of shares are held by institutions.

----


Analysts Set Obalon Therapeutics Inc (OBLN) Target Price at $11.00
Brenda Bartman on Jun 18th, 2018

Obalon Therapeutics logoShares of Obalon Therapeutics Inc (NASDAQ:OBLN) have earned a consensus rating of “Hold” from the seven brokerages that are covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month price target among brokers that have covered the stock in the last year is $11.00.

Several brokerages have weighed in on OBLN. Zacks Investment Research raised Obalon Therapeutics from a “sell” rating to a “hold” rating in a research note on Friday, April 27th. Stifel Nicolaus downgraded Obalon Therapeutics from a “buy” rating to a “hold” rating in a research note on Friday, May 11th. Northland Securities downgraded Obalon Therapeutics from a “market perform” rating to an “underperform” rating in a research note on Friday, May 11th. Canaccord Genuity reaffirmed a “buy” rating and set a $10.00 target price (down previously from $11.00) on shares of Obalon Therapeutics in a research note on Tuesday, March 6th. Finally, ValuEngine raised Obalon Therapeutics from a “sell” rating to a “hold” rating in a research note on Wednesday, May 2nd.




https://www.thestockobserver.com/2018/06/18/analysts-set-obalon-therapeutics-inc-obln-target-price-at-11-00.html